Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective.
about
New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological MalignanciesTreatment Options for Carbapenem-Resistant Enterobacteriaceae InfectionsSystematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniaeCarbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems.Allergic airway inflammation decreases lung bacterial burden following acute Klebsiella pneumoniae infection in a neutrophil- and CCL8-dependent manner.Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries.Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia.Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial DominanceEfficacy of Appropriate Antimicrobial Therapy on the Survival of Patients With Carbapenem Nonsusceptible Klebsiella Pneumoniae Infection: A Multicenter Study in Taiwan.High minimum inhibitory concentration of imipenem as a predictor of fatal outcome in patients with carbapenem non-susceptible Klebsiella pneumoniaeConfronting carbapenemase-producing Klebsiella pneumoniae.Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections.Treatment of multidrug-resistant Gram-negative infections in children.Carbapenemase-producing Gram-negative bacteria: current epidemics, antimicrobial susceptibility and treatment options.Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health.In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.Clinical and molecular characteristics, risk factors and outcomes of Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in the intensive care unitTigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients.High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A retrospective cohort study.Risk factors, outcomes and genotypes of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infection: a three-year retrospective study in a large tertiary hospital in Northern China.Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.
P2860
Q26799580-D6289261-34F4-49E4-90F8-35D2078527C1Q28082546-48F3EF79-BCF1-45D4-ACA0-43C57BFF038BQ30235041-C1DCF3A6-CFEB-4B28-9538-3138A6F851C1Q33623060-8A9E11DC-FE7E-4A57-B3E2-7225EA2DB0EDQ34298356-D87B862F-FA0A-4E22-BC44-2F59645BD783Q35996924-4A179CE6-239D-492C-ACEF-701E01254062Q36075788-B6B31E08-BC4C-4704-8C3E-C5E27489A3F6Q36076066-9D701862-B758-4922-A90C-16227A9B7308Q36194091-5EB373EB-BE7A-49FF-B592-811A3BDA09BDQ37227817-79D8B739-A0AB-4A5A-9DEF-423A5F168CF5Q38135903-D6F95642-4EDE-4192-8D1F-3287D0D53BACQ38145311-136BE3C5-81F9-4DD7-9187-8DC1A749D485Q38185648-466770FA-F754-4CBF-9419-17C04F29A6E0Q38392082-400D4CE3-877F-4F44-8A64-95D3AB042DBBQ39267400-CF911600-A52E-4EC7-82A3-D179703046A4Q42223137-72AE7F5E-A266-4008-98C7-A2E14D3A62DCQ42284521-D9176105-5F16-4544-A39D-ACB1BA0E4434Q43409405-06091889-F670-4903-AF02-0BDF82E85C55Q49711959-BDFD6E99-6065-407D-8E96-036A78F89C07Q50180349-A3828AB3-0FDC-439E-82F5-8551BB2C8BF1Q55132888-B307F2A5-5F91-4E1A-BFE6-79069E664F57
P2860
Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bloodstream infections caused ...... oniae: a clinical perspective.
@en
type
label
Bloodstream infections caused ...... oniae: a clinical perspective.
@en
prefLabel
Bloodstream infections caused ...... oniae: a clinical perspective.
@en
P2093
P2860
P356
P1476
Bloodstream infections caused ...... oniae: a clinical perspective.
@en
P2093
Antonis Markogiannakis
George L Daikos
Leonidas S Tzouvelekis
Maria Souli
P2860
P304
P356
10.1586/ERI.12.138
P577
2012-12-01T00:00:00Z